Pustular psoriasiform eruption with leukocytosis associated with terbinafine.
Papa
C A
CA
Department of Dermatology, Geisinger Medical Center, Danville, Pennsylvania 17822, USA.
Miller
O F
OF
D000935:Antifungal Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004804:Eosinophils / Q000473:pathology; D006801:Humans; D007964:Leukocytosis / Q000139:chemically induced* / Q000473:pathology; D008214:Lymphocytes / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects*; D009504:Neutrophils / Q000473:pathology; D014009:Onychomycosis / Q000188:drug therapy; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D000077291:Terbinafine; D014249:Trichophyton
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine